Pages that link to "Q35790237"

The following pages link to Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology (Q35790237):

Displaying 35 items.

• Mitochondrial DNA haplogroup analysis reveals no association between the common genetic lineages and prostate cancer in the Korean population (Q21562287) (← links)
• 3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores (Q24594248) (← links)
• Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer (Q28272506) (← links)
• The pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretation (Q28768152) (← links)
• Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment (Q30437556) (← links)
• Clinical implications and utility of field cancerization (Q33278836) (← links)
• Uncovering the profile of somatic mtDNA mutations in Chinese colorectal cancer patients (Q33955150) (← links)
• In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells. (Q34013189) (← links)
• Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny (Q34514996) (← links)
• Paired ductal carcinoma in situ and invasive breast cancer lesions in the D-loop of the mitochondrial genome indicate a cancerization field effect (Q34627310) (← links)
• Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer (Q34847101) (← links)
• Evidence for field cancerization of the prostate (Q34982560) (← links)
• The awakening of an advanced malignant cancer: an insult to the mitochondrial genome (Q35718294) (← links)
• Markers of field cancerization: proposed clinical applications in prostate biopsies (Q35991148) (← links)
• Microdissection and analytical PCR for the investigation of mtDNA lesions (Q36796268) (← links)
• Mitochondria and familial predisposition to breast cancer (Q36877040) (← links)
• Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling (Q37069074) (← links)
• Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer (Q37456021) (← links)
• Human mitochondrial DNA: roles of inherited and somatic mutations (Q37648855) (← links)
• Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer (Q37764795) (← links)
• Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer (Q38088721) (← links)
• The mitochondrial genome: a biosensor for early cancer detection? (Q38089243) (← links)
• Mitochondrial genome analysis in biofluids for early cancer detection and monitoring (Q38089732) (← links)
• Mitochondria and cancer: past, present, and future (Q39448724) (← links)
• Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2. (Q39905594) (← links)
• DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair (Q40173900) (← links)
• Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men. (Q40197058) (← links)
• An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population (Q40906299) (← links)
• Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. (Q41205889) (← links)
• Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients (Q41863333) (← links)
• High mitochondria content is associated with prostate cancer disease progression (Q42142812) (← links)
• Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management. (Q42378534) (← links)
• Detecting the somatic mutations spectrum of Chinese lung cancer by analyzing the whole mitochondrial DNA genomes (Q45776742) (← links)
• Mitochondrial oncobioenergetics of prostate tumorigenesis (Q90705652) (← links)
• CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation (Q92444729) (← links)